106 related articles for article (PubMed ID: 15138713)
21. Synergistic effects of parabens on the induction of calbindin-D(9k) gene expression act via a progesterone receptor-mediated pathway in GH3 cells.
Yang H; Nguyen TT; An BS; Choi KC; Jeung EB
Hum Exp Toxicol; 2012 Feb; 31(2):134-44. PubMed ID: 22027501
[TBL] [Abstract][Full Text] [Related]
22. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
23. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
[TBL] [Abstract][Full Text] [Related]
25. [Effects of lanthanum chloride on proliferation and migration of human cervical cancer cell line HeLa cells].
Liu SS; Lu D; Miao LF; Xiong QY; Chen XP; Wang Y; Guo F
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):609-13. PubMed ID: 21029618
[TBL] [Abstract][Full Text] [Related]
26. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
[TBL] [Abstract][Full Text] [Related]
28. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
29. Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells.
De los Santos M; Martínez-Iglesias O; Aranda A
Endocr Relat Cancer; 2007 Dec; 14(4):1021-8. PubMed ID: 18045953
[TBL] [Abstract][Full Text] [Related]
30. Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line.
Barrón-González A; Castro Romero I
Biochem Cell Biol; 2004 Apr; 82(2):335-42. PubMed ID: 15060629
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction.
Lu B; Hu M; Liu K; Peng J
Toxicol In Vitro; 2010 Sep; 24(6):1482-90. PubMed ID: 20656010
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
[TBL] [Abstract][Full Text] [Related]
33. Improved chemosensitivity in cervical cancer to cisplatin: synergistic activity of mahanine through STAT3 inhibition.
Das R; Bhattacharya K; Samanta SK; Pal BC; Mandal C
Cancer Lett; 2014 Aug; 351(1):81-90. PubMed ID: 24831030
[TBL] [Abstract][Full Text] [Related]
34. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance.
Leisching G; Loos B; Botha M; Engelbrecht AM
J Transl Med; 2015 Oct; 13():328. PubMed ID: 26474854
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the BRIP1 ameliorates chemosensitivity to cisplatin by inhibiting Rac1 GTPase activity in cervical carcinoma HeLa cells.
Liu Y; Li H; Zhang R; Dang H; Sun P; Zou L; Zhang Y; Gao Y; Hu Y
Gene; 2016 Mar; 578(1):85-91. PubMed ID: 26680099
[TBL] [Abstract][Full Text] [Related]
36. Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen.
Scambia G; Panici PB; Baiocchi G; Battaglia F; Ferrandina G; Greggi S; Mancuso S
Gynecol Oncol; 1990 Jun; 37(3):323-6. PubMed ID: 2351314
[TBL] [Abstract][Full Text] [Related]
37. Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability.
Pereira DG; Salgado MAR; Rocha SC; Santos HL; Villar JAFP; Contreras RG; Fontes CFL; Barbosa LA; Cortes VF
J Cell Biochem; 2018 Apr; 119(4):3352-3362. PubMed ID: 29130514
[TBL] [Abstract][Full Text] [Related]
38. Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin.
Hussain A; Sharma C; Khan S; Shah K; Haque S
Asian Pac J Cancer Prev; 2015; 16(7):2939-46. PubMed ID: 25854386
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of cisplatin cytotoxicity using cytokines on cervical carcinoma cell lines.
Verma VN; Shenoy CN; Nadkarni JJ
Cancer Biother Radiopharm; 1996 Dec; 11(6):349-54. PubMed ID: 10851495
[TBL] [Abstract][Full Text] [Related]
40. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]